CASTRATION-RESISTANT PROSTATIC CANCER
Clinical trials for CASTRATION-RESISTANT PROSTATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-RESISTANT PROSTATIC CANCER trials appear
Sign up with your email to follow new studies for CASTRATION-RESISTANT PROSTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug trial halted early – what we know
Disease control TerminatedThis study tested an experimental drug called vobramitamab duocarmazine in people with advanced prostate cancer and other solid tumors that had stopped responding to standard treatments. The goal was to see if the drug could shrink tumors or delay cancer growth. The trial was ter…
Matched conditions: CASTRATION-RESISTANT PROSTATIC CANCER
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or combined with other cancer drugs (olaparib or enzalutamide), in people with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The main goals were to check safety and find the right dose. The study was…
Matched conditions: CASTRATION-RESISTANT PROSTATIC CANCER
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 04, 2026 16:31 UTC